Report Highlights
What is Atosiban?
Atosiban is a synthetic nonpeptide desamino-oxytocin analog and a competitive vasopressin or oxytocin receptor antagonist. It is used in after assisted reproduction, preterm birth and to halt premature labour due to its ability to decrease contractions and improve uterine receptivity by reducing intracytoplasmic calcium release and downregulate prostaglandin synthesis.
Global Atosiban Market Outlook
Atosiban is a potent stimulator of myometrial contractions and plays an important role in the initiation of both term and preterm labour. Increasing incidence of preterm birth is driving the growth of the atosiban market. An increase in the incidence of multiple pregnancies, infections and chronic conditions such as diabetes and high blood pressure among pregnant women is the factor to fuel prevalence. According to the World Health Organization, every year, an estimated 15 million babies are born preterm and this figure is rising year by year. Across 184 countries, the rate of preterm birth ranges from 5% to 18% of babies born. The burden of preventing deaths and complications from preterm birth with a healthy pregnancy is high. These deaths incidence is needed to be prevented with current, cost-effective interventions. However, associated regulatory affairs, lack of hospital facilities and inadequate education about prenatal care in rural areas restrains the growth of the market. Also, atosiban is approved only in 67 countries, excluding the USA and Japan.
Global Atosiban Market Competitive Landscape
The “Global Atosiban Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such Ferring Pharmaceuticals, Sun Pharma, Shanghai Soho-Yiming Pharmaceuticals, EVER Pharma, Hangzhou Longshine Bio-Tech, Cayman Chemical and Neore Pharmaceutical. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More